Centessa Pharmaceuticals (CNTA)

• Market cap: $3.71B
• 1 day: 6.31%
• 5 days: 22.77%
• 1 month: 23.2%
• 3 months: 56.52%
• 6 months: 125.02%
• Year to date: 57.77%
• 1 year: 57.77%
• 5 years: 26.94%
• 10 years: 26.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Employees: 114